MedTrace Logo

Sayana Press UK Self-Injection Study

NCT03034057 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 169

Last updated 2019-10-18

Study results available
· View outcomes & findings →

Summary

A one-year evaluation of Sayana Press self injection in women of reproductive age in the United Kingdom (UK).

Conditions

  • Contraception

Interventions

DRUG

Sayana Press

Sayana Press in the Uniject injection system

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-23
Primary Completion
2018-12-07
Completion
2018-12-07

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03034057 on ClinicalTrials.gov